| It should be noted that the multiple sclerosis drugs
currently in use to treat MS are immunomodulatory. This means
the approved drugs used specifically in the treatment of multiple sclerosis
have a direct effect on the workings and efficiency of the normal immune
system and therefore their use carries the (theoretical) risk of compromising
the body's ability to fight infection and may also interfere with the
body's tumor surveillance mechanisms.
The multiple sclerosis treatment drugs do exert a
considerable influence on the immune system in multiple sclerosis
patients and any decision to embark on a course of multiple
sclerosis drugs treatment must be carefully weighed against the
potential for adverse side effects.
Some of the reported side effects of the
multiple sclerosis drugs, regardless of the course and duration of
multiple sclerosis exacerbations or progression, cannot and
should not, be disregarded, or viewed by anyone as a reasonable
trade-off of drug treatment v's drugs side effects.
|
